News archive for Lorens/Aarsaether Lab
UiB spin-off biotech company BergenBio announced that their drug bemcentinib is frast-tracked in a phase-II clinical trial as a potential treatment against COVID-19.
The candidate will give a trial lecture and defend her doctoral thesis with the title: “The Receptor Tyrosine Kinase Axl in Tumour Phenotyptic Plasticity and Acquired Resistance to Cancer Targeted- and Immunotherapy"
The candidate will give a trial lecture and defend her doctoral thesis with the title: “The role of AXL and the tumor microenvironment in cancer cell plasticity and therapy responses"
"The role of AXL and the tumor microenvironment in cancer cell plasticity and therapy responses"
A research team led by James Lorens at the Department of Biomedicine and CCBIO used new technology to determine how breast tissue changes with age may contribute to breast cancer risk. The research is published in Cell Reports, with a commentary on Eureka Alert.
- May 2020 (1)
- May 2019 (1)
- March 2019 (1)
- February 2019 (1)
- April 2018 (1)